Ticker League

EBITDA Margin for Edwards Lifesciences (EW)

As of · Reported

Metric

TTM

22.8%

YoY change

−8.12pp

Trough year (2004)

10.7%

Peak year (2014)

53.1%

EBITDA Margin history chart for Edwards Lifesciences (EW) from 1999 to 2025

Latest: 23.6%

EBITDA Margin change chart for Edwards Lifesciences (EW) from 1999 to 2025

Latest: −8.12pp

EBITDA Margin history table for Edwards Lifesciences (EW) from 1999 to 2025

  • 202523.6%-8.12pp
  • 202431.7%+1.04pp
  • 202330.6%-5.79pp
  • 202236.4%+0.30pp
  • 202136.1%+11.63pp
  • 202024.5%-5.60pp
  • 201930.1%+6.66pp
  • 201823.4%-9.76pp
  • 201733.2%+5.28pp
  • 201627.9%-0.43pp
  • 201528.3%-24.80pp
  • 201453.1%+24.30pp
  • 201328.8%+5.00pp
  • 201223.8%+3.30pp
  • 201120.5%-2.07pp
  • 201022.6%-5.08pp
  • 200927.7%+9.33pp
  • 200818.4%-1.23pp
  • 200719.6%-3.52pp
  • 200623.1%+4.55pp
  • 200518.6%+7.82pp
  • 200410.7%-10.65pp
  • 200321.4%+8.24pp
  • 200213.1%+1.42pp
  • 200111.7%-9.30pp
  • 200021.0%-1.19pp
  • 199922.2%—

EBITDA Margin values are taken from Edwards Lifesciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Edwards Lifesciences (EW)

According to Edwards Lifesciences's latest reported financial statements, the company's latest reported EBITDA margin is 22.8%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Edwards Lifesciences (EW) most recent annual EBITDA margin stands at 23.56% (2025) – contracted 8.1 percentage points year-over-year.

53.13% stands as the all-time-high annual EBITDA margin, posted in 2014, against a low of 10.74% during 2004.

Edwards Lifesciences EBITDA Margin by Year

Edwards Lifesciences EBITDA Margin 2025: 23.6%

Edwards Lifesciences EBITDA margin in 2025 was 23.56%, contracted 8.1 percentage points from 2024.

Edwards Lifesciences EBITDA Margin 2024: 31.7%

2024's EBITDA margin for Edwards Lifesciences came in at 31.68%, expanded 1.0 percentage points from 2023.

Edwards Lifesciences EBITDA Margin 2023: 30.6%

Edwards Lifesciences posted EBITDA margin of 30.64% in 2023, contracted 5.8 percentage points from 2022.

Edwards Lifesciences EBITDA Margin 2022: 36.4%

In 2022, Edwards Lifesciences reported EBITDA margin of 36.42%, expanded 0.3 percentage points from 2021.

Edwards Lifesciences EBITDA Margin 2021: 36.1%

Edwards Lifesciences EBITDA margin in 2021 was 36.12%.

See more financial history for Edwards Lifesciences (EW).

Sector peers by EBITDA Margin

Healthcare peers of Edwards Lifesciences (EW), ranked by their latest EBITDA margin

Frequently asked questions

Edwards Lifesciences (EW) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview
Capital Return

No dividends paid by this company.